GlassScriptPhysician profile
John Eric Lankenau
NPI 1275561425
$669,497.26
in general payments reported to CMS, 2019-2025
13 companies · $74K in 2025
The $74K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121K · 2020: $90K · 2021: $90K · 2022: $94K · 2023: $103K · 2024: $98K · 2025: $74K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $272K · Consulting Fee: $2,000 · Food and Beverage: $775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $272,206.77 |
| Consulting Fee | $2,000.00 |
| Food and Beverage | $775.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $610,839.92 | 2019-2025 | Firebird, Physio-Stim, Forza |
| Genesys Orthopedics Systems, L.L.C. | $55,187.90 | 2019-2025 | Lumbar Plate, Apache, Apache |
| Ctl Medical Corporation | $2,037.60 | 2024 | Spinal |
| Life Spine, INC. | $449.35 | 2023-2024 | Prolift, Prolift Lateral |
| Si-Bone, INC. | $327.19 | 2019-2024 | |
| Zimvie INC. | $246.15 | 2022 | |
| Biocircuit Technologies INC | $133.21 | 2025 | Nerve Tape |
| Medtronic USA, INC. | $91.52 | 2019-2020 | |
| Providence Medical Technology, INC. | $56.11 | 2021-2022 | |
| Medtronic, INC. | $44.44 | 2021-2024 | Osteocool Rf Ablation System |
| Spinal Elements, INC. | $31.80 | 2023 | |
| Choice Spine, LLC | $28.57 | 2020 | |
| Spineology INC. | $23.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lankenau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.